Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results

Author： Thuret Isabelle Hacini Maya Pégourié-Bandelier Brigitte Gardembas-Pain Martine Bisot-Locard Ségolène Merlat-Guitard Annabelle Bachir Dora

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.14, Iss.6, 2009-12, pp. : 315-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

By Kontoghiorghes G.J. Pattichi K. Hadjigavriel M. Kolnagou A.

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 211-223

Elsevier

Access to resources Recommend Favorite

Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)

By Kontoghiorghes G.J. Pattichi K. Hadjigavriel M. Kolnagou A.

Transfusion Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 211-223

Elsevier

Access to resources Recommend Favorite

Iron-chelation therapy with oral chelators in patients with thalassemia major

By Uygun Vedat

Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. : 50-55

Maney Publishing

Access to resources Recommend Favorite

Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

By Breuer W. Ermers M.J.J. Pootrakul P. Abramov A. Hershko C. Ioav Cabantchik Z.

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 241-242

Elsevier

Access to resources Recommend Favorite

Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

By Breuer W. Ermers M.J.J. Pootrakul P. Abramov A. Hershko C. Ioav Cabantchik Z.

Transfusion Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 241-242

Elsevier

Access to resources Recommend Favorite